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in aberrant connective tissue destruction. Expression of MMPs is 
regulated primarily at the transcriptional level where the promoter 
of the genes responds to different regulators [8]. Some functional 
polymorphisms have been described in the regulatory region of 
MMPs genes [5]. Because destructive enzymes of the MMPs family 
are involved in this process, allele polymorphisms of MMPs genes are 
interesting candidates for analyses of the influence, susceptibility and 
severity of chronic periapical lesions (CPLs).
Subfamily of human colagenases has three members, from which 
MMP-1 (fibroblast type of colgenase, colagenase-1) is one of our 
interest [9]. Gen of the MMP-1 is localized on chromosome 11q22 
and its expression was shown in various types of healthy cells (stromal 
fibroblasts, macrophage, endothelial and epithelial cells), as well as in 
different inflammatory and carcinoma cells [10]. 
Level of expression of MMP-1 can be under the influence of 
different single nucleotide polymorphism in promontory region. 
Insertion or deletion of the guanine from the position -1607 can be 
identified in humans in promoter of the gen of MMP-1 developing two 
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Introduction
Matrix metalloproteinases (MMPs) are zinc and calcium dependent 
enzymes capable of degrading almost all extracellular matrix and 
basement membrane components [1]. This group of proteolytic 
enzymes believed to be implicated in the breakdown of extracellular 
matrix in normal physiological processes, such as embryonic 
development, blastocyst implantation, organ morphogenesis, nerve 
growth, ovulation, cervical dilatation, postpartum uterine involution, 
endometrial cycling, hair follicle cycling, bone remodeling, wound 
healing, angiogenesis, apoptosis, etc. [2].
Matrixins play a critical role in pathological processes (e.g. 
arthritis, cancer, cardiovascular disease, nephritis, neurological disease, 
breakdown of blood brain barrier, periodontal disease, skin ulceration, 
gastric ulcer, corneal ulceration, liver fibrosis, emphysema, fibrotic 
lung disease, etc. [3]. According to the important role of MMPs in 
inflammation [4], it has been shown that genetic variation affecting 
the expression of MMPs influences the susceptibility and progression 
of various oral diseases [5]. Matrix metalloproteinases are strongly 
associated with levels of inflammation and play a major role in bone 
remodeling and bone resorption [6].
Bone matrix is comprised mostly of mineralized fibrillar type I 
collagen. MMPs are capable of cleaving native, nondenatured collagens 
with long uninterrupted triple helices and can function as collagenases 
in vivo [7].
Expression of MMPs is low in normal cells, and these low levels allow 
for healthy connective tissue remodeling. In pathologic conditions, 
however, the level of MMPs expression increases considerably, resulting 
Abstract
Background/Aim: Matrix metalloproteinases (MMPs) are zinc and calcium dependent enzymes capable of 
degrading almost all extracellular matrix and basement membrane components. This group of proteolytic enzymes is 
believed to be implicated in the breakdown of extracellular matrix in normal physiological processes, as well as playing 
an important role in many destructive pathological oral processes, such as periodontal tissue destruction, root caries, 
tumor invasion, and chronic periapical inflammation (CPL). The aim of this study was to analyze polymorphism in the 
gene MMP-1 and their association and influence on clinical manifestation of chronic periapical lesions in order to provide 
new advances regarding the involvement of MMPs in various oral diseases associated with the inflammatory process.
Materials and methods: A total of 240 unrelated Macedonian subjects were included in the present study. 
Polymorphism -1607 1G/2G in the gene MMP-1 detected with restriction enzymes AluI, XmnI and polymorphism -519 
A/G in the gene MMP-1 detected with restriction enzyme KpnI was studied in 120 patients with CPL and 120 controls 
without any signs of chronic or acute inflammatory process in the jaw. The amplification of the region of selected gene 
was made with polymerase chain reactionrestriction fragment length polymorphism (PCR-RFLP). 
Results: Our results showed that there was a differences in the allele and genotype frequencies of the MMP-1 
polymorphism between patients with CPL and controls (p<0.05). Also this study suggests that MMP-1 polymorphism 
-1607 1G/2G detected with restriction enzymes AluI, XmnI was a risk for expression of CPL (OR=18.38<4.06<OR<115.46; 
OR=7.73<3.1<OR<19.55) and MMP-1 polymorphism -519 A/G detected with restriction enzyme KpnI was a risk for 
expression of CPL (OR=12.11<4.64<OR<32.30). 
Conclusions: Detection of this genetic polymorphism is relevant for obtaining providential treatment of patients who 
are at high risk of chronic periapical.
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different alleles: one has single guanine (1G), and the other two guanine 
(2G) [11]. 
Patients who carried 2G allele have predisposition to develop several 
types of carcinoma or their rapid progression [12] to develop arthritis 
[5], arteriosclerosis, periodontitisot [13], unsuccessful osteointegration 
of the implant [14], and coronary heart disease in patients with diabetes 
mellitus [15]. 
The aim of this study was to analyze polymorphism in the gene 
MMP-1 and their association and influence on clinical manifestation 
of chronic peripical lesions in order to provide new advances regarding 
the involvement of MMPs in various oral diseases associated with the 
inflammatory process. 
Patients and Method
Patients’ samples
Selection of the patients was made according to internal criteria, 
on the basis of sated clinical diagnosis, after detail analysis and clinical 
examination with analysis of X-ray changes. In this study patients who 
have antibiotic or immune-suppressive therapy, patients with systematic 
disorders and infections, patients with hypertension, patients with 
diabetes mellitus, women with pregnancy, menopause women and 
children under the age of 18th and those patients who have clinical signs 
of parodontopathia were excluded. 
Two groups were formed. First group was formed from 40 patients 
after clinically and radiographic verified chronic periapical lesion. Only 
the patients with clinical diagnosis Parodontitis chronica periapicalis 
granulomatosa seu granulom (PHPG) were included. Second (control) 
group formed 120 patients without endodontic treated teeth and 
absents of chronic periapical process or acute odontogenic infection. 
From the local dental status trough clinical methods in patients with 
clinical diagnosis, PHPG and exhaustive clinical examination presence 
of subjective symptoms: pain, percussion and palpation sensitivity and 
objective symptoms: swelling, drainage of exudates from the root canal 
and presence of fistula. These dates were expressed by CPI (clinical 
periapical index). 
From the X-ray analyses following parameters in patients 
with chronic periapical lesions were registered: condition of the 
parodontium, presence of chronic periapical lesions, determination of 
its limits, and presence of bone resorption. 
All the teeth with chronic periapical lesions were non vital and we 
used vitality test for diagnostic measures. Patients with PHPG undergo 
the surgical procedure. Before the resection of the apex, the root canals 
of the teeth were filled with same material (Thymol-phosphate cement). 
Teeth from the upper and lower jaw and single root or teeth with two 
roots were examined in this study.
In the aseptic condicions, from each patient with vene-punction, 
sample of vein blood (10 ml) was taken in sterile epruvete (Vaccutainer®) 
in which was anticoagulant (EDTA.Na2). Ich sample was frozen at -80°C 
as soon as possible and stored until the analysis.
DNA preparation
Standard isolation of genomic DNA from the nuclear cells was 
made with natrium chlorid extraction and afterwords precipitation with 
ethanol [16]. Samples of DNA izolates were aliqvated in few epruvetes, 
from wich, one was kept from +4°C till +8°C, and that one was used 
for analysis. The other EDTA tubes were kept as a reserve in the bank 
of samples at temperature from -18°C till -20°C. Amplification of the 
regions of elected genes was made with polymerase chain reaction 
(PCR) and performed in PCR machine (Perkin-Elmer Gene Amp System 
2400) (Table 1).
Presence or absence of some normal or mutated sequence in PCR 
product followed by restriction digestion results with different size 
of fragments.  Successful amplification was verified with presence of 
electrophoresis marker (PCR Marker, Bio-Rad) with agrarelectrophoreze 
(Bio-Rad, USA). Production of digestion were vizualizate with 
fluoroscence painting of the gel with etidium bromid.
Statistical Analysis
Differences between two parameters in series with numeric 
characteristic were tested with Pearson Chi-Square test. Statistical 
significance shows that results with values p<0.05. Tests for Hardy-
Weinberg equilibrium among groups were conducted with aim to 
examined presence of selective force who effect on distribution of 
the alleles using observed genotype frequencies and a χ2 test with 
one degree of freedom. Risk for developing chronic periapical lesion 
according to gene polymorphism of MMP-8 (associative or protective 
roll) was determinate with odd ratio (OR).
Results 
Representation of the polymorphism -1607 1G/2G of the gene 
of MMP-1 detected with restricted enzyme AluI in the patients from 
examined groups is shown in Table 2. Statistical analysis confirm that 
there is a statistical significance between gene poymorphism of MMP-1 
detected with restriction enzyme AluI and CPL (Pearson Chi-square: 
40.9120, df=2, p=0.000000). Polymorphism -1607 1G/2G for the gene 
of MMP-1 detected with restictive enzyme AluI was risk factor for 
expression of chronic periapical lesion (OR=18.38<4.06<OR<115.46).
Representation of the polymorphism -1607 1G/2G of the gene of MMP-
1 detected with restricted enzyme XmnI in the patients from examined 
groups is shown in Table 3. 
Statistical analysis confirm that there is a statistical significance 
Gene
Polymor-
phism Pramer PCR conditions
Length of PCR 
ampli-fication
Restri-ction 
enzyme
Restri-ction
digestion
MMP-1 -1607 1G/2G
(F) 5'-TGA CTT TTA AAA CAT AGT CTA TGT TCA-3'
(R) 5'- TCT TGG ATT GAT TTG TTG AGA TAA GTC 
ATA GC-3'
35 cycles:
94°C 30 s,
54°C 30 s,
72°C 30 s
269 bp AluI (241+28) bp
MMP-1 -1607 1G/2G (F) 5'-TCG TGA GAA TGT CTT CCC ATT-3'(R) 5'-TCT TGG ATT GAT TTG AGA TAA GTC ATA-3'
35 cycles: 93°C30 s,
5°C 30 s, 72°C 30 s, 
72°C 5 min
118 bp XmnI (29+89) bp
MMP-1 -519  A/G (F) 5'-CAT GGT GCT ATC GCA ATA GGG T-3'(R) 5'-TGC TAC AGG TTT CTC CAC ACA C-3'
30 cycles: 94°C 30 s, 
49°C 30 s, 72°C 20 s, 
72°C 4 min
200 bp KpnI (176+24) bp
Table 1: Sequence of PCR primers with their restriction enzyme.
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Frequency of the genotypes was  f(1G/1G)=0.7; f(1G/2G)=0.2; 
f(2G/2G)=0.1 and p>0.05 (p=0.0002) witch shows that there is no 
equilibrium (Tables 6 and 7).  Detected frequence of 2G allel in 
polymorphs -1607 1G/2G of the gene for MMP-1 detected with 
restricted enzyme AluI was significant higher in patients with CPL than 
those from the control group (f(2G)=0.30). Frequency of the genotypes 
was f(1G/1G)=0.0; f(1G/2G)=0.5 f(2G/2G)=0.5 and p>0.05 (p=0.3133) 
witch shows that there is no equilibrium (Tables 7 and 8).
Frequency of the genotypes was f(1G/1G)=0.5; f(1G/2G)=0.4; 
f(2G/2G)=0.1 and p>0.05 (p=0.8259) witch shows that there is 
no equilibrium (Tables 8 and 9).Detected frequence of 2G allel in 
polymorphs -519 A/G of the gene for MMP-1 detected with restricted 
enzyme KpnI was significant higher in patients with CPL than those 
from the control group (f(G)=0.05). With that we can confirm 
protective role of A allele in this polymorphism for developing an 
inflammatory process.  Frequency of the genotypes was f (A/A)=0.5; 
f(A/G)=0; f(G/G)=0.2 and p<0.05 (p=0.0461) witch shows that there 
is an equilibrium (Tables 9 and 10). Frequency of the genotypes was 
f(A/A)=0.9; f(A/G)=0.1; f(G/G)=0.0 and p>0.05 (p=0.5988) witch 
shows that there is no equilibrium (Table 10). 
between gene poymorphism of MMP-1 detected with restriction 
enzyme XmnI and CPL (Pearson Chi-square: 57.5222, df=2, 
p=0.000000). Polymorphism -1607 1G/2G for the gene of MMP-1 
detected with restictive enzyme AluI was risk factor for expression of 
chronic periapical lesion (OR=7.73<3.1<OR<19.55). Representation 
of the polymorphism -519 A/G of the gene of MMP-1 detected with 
restricted enzyme KpnI in the patients from examined groups is shown 
in Table 4. 
Statistical analysis confirm that there is a statistical significance 
between gene poymorphism of MMP-1 detected with restriction 
enzyme KpnI and CPL (Pearson Chi-square: 45.8285, df=2, 
p=0.000000). Polymorphism -519 A/G for the gene of MMP-1 detected 
with restictive enzyme KpnI was risk factor for expression of chronic 
periapical lesion  (OR=12,11<4.64<OR<32.30) (Table 5). Detected 
frequence of 2G allel in polymorphs -1607 1G/2G of the gene for 
MMP-1 detected with restricted enzyme XmnI was significant higher 
in patients with CPL than those from the control group (f(2G)=0.18). 
With that we can confirm protective role of 1G allele for developing an 
inflammatory process. Frequency of the genotypes was f(1G/1G)=0.2; 
f(1G/2G)=0.2; f(2G/2G)=0.6 and p<0.05 (p=0.0002) witch shows that 
there is an equilibrium (Tables 5 and 6). 
Polymorphism
of MMP-1 detected with restricted enzyme AluI Number
Examined groups
Total
Chronic periapical lesions Control group
-/- (homozygotes for absence)
N 2 59 61
% 5% 49.2% 43.6%
-/+ (homozygotes for absence)
N 19 10 29
% 47.5% 8.3% 20.7%
-/+ (homozygotes for absence)
N 19 51 70
% 47.5% 42.5% 50%
Table 2: Representation of the polymorphism  -1607 1G/2G for the gene of MMP-1 detected with restristed enzyme AluI in patients from examined  groups.
Polymorphism of MMP-1 detected with restricted enzyme KpnI Number
Examined groups
Total
Chronic periapical lesions Control group
-/- (homozygotes for absence)
N 18 109 127
% 45% 90.8% 90.7%
+/+ (homozygotes for absence)
N 9 / 9
% 22.5% / 6.4%
-/+ (homozygotes for absence)
N 13 11 24
% 32.5% 9.2% 17.1%
Table 3. Representation of the polymorphism  -519 A/G for the gene of MMP-1 detected with restristed enzyme KpnI in patients from examined  groups
Polymorphism of MMP-1 detected with restricted enzyme KpnI Number
Examined groups
Total
Chronic periapical lesions Control group
-/- (homozygotes for absence)
N 18 109 127
% 45% 90.8% 90.7%
+/+ (homozygotes for absence)
N 9 / 9
% 22.5% / 6.4%
-/+ (homozygotes for absence)
N 13 11 24
% 32.5% 9.2% 17.1%
Table 4. Representation of the polymorphism  -519 A/G for the gene of MMP-1 detected with restristed enzyme KpnI in patients from examined  groups.
Genotype 1G/1G 1G/2G 2G/2G Total Frequency of the alleles
Number n 9 7 24 40 80
Allel 1G 18 7 0 25 0.31
Allel 2G 0 7 48 55 0.69
Table 5. Frequency of the allels in the polymorphism  -1607 1G/2G for the gene of MMP-1 detected with restristed enzyme XmnI in patients with CPL.
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Discussion
MMPs play an important role during periapical pathology 
development [17], and it has been suggested that the modality of root 
canal treatment could interfere with MMPs expression [18].
Due to their various roles in bone remodeling, immune responses, 
caries, and dental development, it is hypothesize that variation in MMPs 
and TIMP genes may alter the level of bone destruction and remodeling 
and contribute to the formation of more extensive periapical lesions in 
teeth affected by deep carious lesions [19,20].
Results in our study indicate that individual genetic predisposition 
have influence on periapical lesion formation. We can confirm that 
polymorphism of the gene for MMP-1 contributes for increasing 
individual frequency of apical tissue destruction as a reaction to deep 
caries lesion. Our results are in correlation with findings of Rutter et 
al. [11] in which is show that this polymorphism can have functional 
consequences because can affect the function of MMP-1, as well as, is 
polymorphism who is candidate with strong biological significance for 
developing inflammatory process. Also our result are in correlation 
with finding of Cao et al. [21] in which genetic variations in promontory 
region  of the gene of MMP-1 have influence on the transcription 
level and as a results of this, the gen of MMP-1 have crucial role in 
degradation of connected tissue in periodontis. 
Beside this, Itagaki et al. [9], have not detected differences between 
allele of the gene of MMP-1 and genotypic distribution in healthy 
Japanese and those with chronic periodontitis. Findings about the 
detected frequence of G allel in polymorphs -519 A/G of the gene for 
MMP-1in our study are in relationship with findings of Oh H-S et 
al. [22], where is observed similar distribution of the genotypes and 
frequencies of the alleles. 
Polymorphism -1607 1G/2G for the gene MMP-1 detected with 
restristed enzymes Xmnl and Alul is an risck factor for developing 
chronic periapical lesion. Individuals who are carriers of 2G/2G 
genotype and individuals with 1G/2G genotype (2G carriers)  in this 
polymorphism shows affection for developing chronic periapical lesion. 
Polymorphism -519 A/G for the gene MMP-1 detected with restristed 
enzymes Kpnl is a risck for developing chronic periapical lesion and 
individuals who are carriers of G/G genotype and individuals with 
A/G genotype (G carriers) in this polymorphism shows affection for 
developing chronic periapical lesion. 
Conclusion
With this study we can identify the genetic factors that are of 
enormously meaning for establishing the risk profile of the patients who 
have affection for developing chronic periapical lesions in Macedonian 
population, and variations in gene alleles of the MMP-1 are markers 
for monitoring the risk and progression of this inflammatory process. 
Genotype 1G/1G 1G/2G 2G/2G Total Frequency of the alleles
Number n 83 30 7 120 240
Allel 1G 166 30 0 196 0.82
Allel 2G 0 30 14 44 0.18
Genotype 1G/1G 1G/2G 2G/2G Total Frequency of the alleles
Number n 83 30 7 120 240
Allel 1G 166 30 0 196 0.82
Allel 2G 0 30 14 44 0.18
Table 6. Frequency of the allels in the polymorphism  -1607 1G/2G for the gene of MMP-1 detected with restristed enzyme XmnI in patients from controle group.
Genotype 1G/1G 1G/2G 2G/2G Total Frequency of the alleles
Number n 2 19 19 40 80
Allel 1G 4 19 0 23 0.29
Allel 2G 0 19 38 57 0.71
Table 7. Frequency of the allels in the polymorphism  -1607 1G/2G for the gene of MMP-1 detected with restristed enzyme AluI in patients with CPL.
Genotype 1G/1G 1G/2G 2G/2G Total Frequency of the alleles
Number n 59 51 10 120 240
Allel 1G 118 51 0 169 0.70
Allel 2G 0 51 20 71 0.30
Table 8. Frequency of the allels in the polymorphism  -1607 1G/2G for the gene of MMP-1 detected with restristed enzyme AluI in patients from controle group.
Genotype A/A A/G G/G Total Frequency of the alleles
Number n 10 22 8 40 80
Allel A 20 22 0 42 0.52
Allel G 0 2 16 38 0.48
Table 9. Frequency of the allels in the polymorphism  -519 A/G for the gene of MMP-1 detected with restristed enzyme KpnI in patients with CPL.
Genotype A/A A/G G/G Total Frequency of the alleles
Number n 59 51 10 120 240
Allel A 118 51 0 169 0.70
Allel G 0 51 20 71 0.30
Table 10. Frequency of the allels in the polymorphism   -519 A/G  for the gene of MMP-1 detected with restristed enzyme KpnI in patients from 
controle group.
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Our findings are fundamental for identification of gene 
polymorphism of MMP-1 in Macedonian population, as a starting 
point in further investigations of MMPs gene expression, enable to 
predict the course and development of clinical sign of inflammatory 
process, indirectly pointed the adequate therapeutic method. 
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